June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of standard, inexpensive testing which may help reduce disparities in care and lower the amputation risk for people with peripheral artery disease.

June 20, 2023 — The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions. 

The FDA approval of iTFlow will enable healthcare professionals to make more precise and effective decisions in patient care. 

June 20, 2023 — Pāáč‡ini, an AI-powered chatbot developed by doctors for doctors, has officially launched, aiming to empower clinicians with a cutting-edge tool that enhances precision, accelerates complex computations, and minimizes medical judgment errors.

June 19, 2023 — Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts.

June 19, 2023 — AliveCor, a global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking collaboration with Luscii, Europe's market leader in remote patient monitoring and virtual ward provider.

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced the 24-month results of the DETOUR2 Study.

June 16, 2023 — A promising emerging treatment (hypercapnia) for comatose adult cardiac arrest patients has been found to yield similar results to current treatment, in a new study published today in the prestigious medical journal New England Journal of Medicine (NEJM). 

June 16, 2023 — Esperion presented results from an analysis comparing the cardiovascular risk reduction benefits of bempedoic acid treatment with statin therapy per unit decrease in

June 15, 2023 — Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now